Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.The maker of glucose monitoring devices said investigations of its San Diego,

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous glucose monitor maker’s facilities last year. | Dexcom has received a warning letter from the FDA,

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities, sending its shares down nearly 7% after the bell.